BioMarin Pharmaceutical Inc. (BMRN)

BioMarin Pharmaceutical Revenue

BioMarin Pharmaceutical had revenue of $989.71M in the quarter ending June 30, 2026, with 19.91% growth. This brings the company's total for the last twelve months to $3.41B, up 11.20% year-over-year. In the year 2025, BioMarin Pharmaceutical had annual revenue of $3.22B with 12.87% growth. That makes BioMarin Pharmaceutical the 3,490th largest company in the world by revenue and 969th in the United States.

• Revenue (ttm): $3.41B
• Revenue Growth: +11.20%
• P/S Ratio: 3.26
• Revenue / Employee: $1,057,626
• Employees: 3,221
• Market Cap: 11.13B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• VOXZOGO 926.92M 28.8%
• VIMIZIM 792.05M 24.6%
• NAGLAZYME 485.40M 15.1%
• PALYNZIQ 433.31M 13.5%
• ALDURAZYME 208.51M 6.5%
• BRINEURA 186.40M 5.8%
• KUVAN 99.53M 3.1%
• Other 89.13M 2.8%

By Geography

Chart

• United States 1.10B 34.3%
• Europe 874.33M 27.1%
• Rest of World 544.47M 16.9%
• Latin America 435.48M 13.5%
• Other 208.51M 6.5%
• Royalty and Other 53.49M 1.7%

Fiscal year ended Dec 31, 2025 See the full BioMarin Pharmaceutical breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.22B	367.34M	12.87%
Dec 31, 2024	2.85B	434.69M	17.97%
Dec 31, 2023	2.42B	323.19M	15.42%
Dec 31, 2022	2.10B	249.76M	13.53%
Dec 31, 2021	1.85B	-14.18M	-0.76%
Dec 31, 2020	1.86B	156.41M	9.18%
Dec 31, 2019	1.70B	212.84M	14.27%
Dec 31, 2018	1.49B	177.57M	13.52%
Dec 31, 2017	1.31B	196.79M	17.62%
Dec 31, 2016	1.12B	226.96M	25.50%
Dec 31, 2015	889.90M	140.61M	18.77%
Dec 31, 2014	749.28M	200.80M	36.61%
Dec 31, 2013	548.49M	47.76M	9.54%
Dec 31, 2012	500.72M	59.37M	13.45%
Dec 31, 2011	441.36M	65.09M	17.30%
Dec 31, 2010	376.27M	51.61M	15.90%
Dec 31, 2009	324.66M	28.16M	9.50%
Dec 31, 2008	296.49M	172.82M	139.74%
Dec 31, 2007	123.67M	39.46M	46.86%
Dec 31, 2006	84.21M	58.54M	228.06%
Dec 31, 2005	25.67M	-	-

Data Source: Fiscal.ai Last updated: Aug 6, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 27, 2026

Data Sources Report a data error